Covetrus Inc (NASDAQ:CVET) was down 1.7% during trading on Friday . The company traded as low as $25.68 and last traded at $25.39. Approximately 48,811 shares were traded during trading, a decline of 97% from the average daily volume of 1,541,107 shares. The stock had previously closed at $25.83.

A number of equities research analysts recently commented on CVET shares. Raymond James started coverage on Covetrus in a research note on Wednesday, February 27th. They set an “outperform” rating and a $45.00 price objective for the company. Stifel Nicolaus initiated coverage on shares of Covetrus in a research note on Wednesday. They issued a “hold” rating and a $30.00 price objective for the company. Svb Leerink reaffirmed an “outperform” rating on shares of Covetrus in a report on Wednesday, March 20th. Credit Suisse Group initiated coverage on shares of Covetrus in a report on Thursday, April 4th. They issued a “neutral” rating and a $35.00 target price on the stock. Finally, William Blair initiated coverage on shares of Covetrus in a report on Tuesday, February 12th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $36.67.

The company has a debt-to-equity ratio of 0.51, a current ratio of 1.82 and a quick ratio of 0.93.

Covetrus (NASDAQ:CVET) last released its quarterly earnings data on Wednesday, May 15th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.03). The business had revenue of $941.00 million for the quarter, compared to the consensus estimate of $993.41 million. During the same quarter in the prior year, the firm posted $0.18 earnings per share. The company’s quarterly revenue was down .6% compared to the same quarter last year. Equities analysts anticipate that Covetrus Inc will post 0.63 earnings per share for the current year.

In other news, Director Betsy S. Atkins sold 150,845 shares of Covetrus stock in a transaction on Friday, May 17th. The shares were sold at an average price of $27.80, for a total value of $4,193,491.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Ludlow sold 81,498 shares of Covetrus stock in a transaction on Friday, May 17th. The shares were sold at an average price of $28.01, for a total transaction of $2,282,758.98. The disclosure for this sale can be found here. Insiders sold a total of 233,028 shares of company stock worth $6,495,656 over the last ninety days.

COPYRIGHT VIOLATION WARNING: “Covetrus (CVET) Trading Down 1.7%” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://theolympiareport.com/2019/05/24/covetrus-cvet-trading-down-1-7.html.

About Covetrus (NASDAQ:CVET)

Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Featured Article: Growth and Income Funds

Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.